Revealing anti-inflammatory mechanisms of soy isoflavones by flow: modulation of leukocyte-endothelial cell interactions
Departments of 1 Pathology, 2 Pharmacology, and 3 Anesthesiology, 4 Purdue-University of Alabama at Birmingham Botanical Center for Age-Related Disease, and 5 Center for Free Radical Biology, University of Alabama at Birmingham; and 6 Research Service, Birmingham Veterans Affairs Medical Center, Bir...
Saved in:
Published in | American journal of physiology. Heart and circulatory physiology Vol. 289; no. 2; pp. H908 - H915 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.08.2005
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Departments of 1 Pathology, 2 Pharmacology, and 3 Anesthesiology, 4 Purdue-University of Alabama at Birmingham Botanical Center for Age-Related Disease, and 5 Center for Free Radical Biology, University of Alabama at Birmingham; and 6 Research Service, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama; and 7 Department of Pathology, Louisiana State University, Shreveport, Louisiana
Submitted 2 August 2004
; accepted in final form 28 March 2005
The antiatherogenic effects of soy isoflavone consumption have been demonstrated in a variety of studies. However, the mechanisms involved remain poorly defined. Adhesion of monocytes to vascular endothelial cells is a key step within the inflammatory cascade that leads to atherogenesis. Many factors, including the physical forces associated with blood flow, regulate this process. Using an in vitro flow assay, we report that genistein, a principal component of most isoflavone preparations, inhibits monocyte adhesion to cytokine (TNF- )-stimulated human vascular endothelial cells at physiologically relevant concentrations (01 µM). This effect is absolutely dependent on flow and is not observed under static conditions. Furthermore, this inhibition was dependent on activation of endothelial peroxisomal proliferator-activated receptor- . No significant role for other reported properties of genistein, including antioxidant effects, inhibition of tyrosine kinases, or activation of estrogen receptors, was observed. Furthermore, the antiadhesive effects of genistein did not occur via modulation of the adhesion molecules E-selectin, ICAM-1, VCAM-1, or platelet-endothelial cell adhesion molecule-1. These data reveal a novel anti-inflammatory mechanism for isoflavones and identify the physical forces associated with blood flow and a critical mediator of this function.
inflammation; genistein; peroxisomal proliferator-activated receptor- ; atherosclerosis; monocytes
Address for reprint requests and other correspondence: R. P. Patel, Dept. of Pathology, Univ. of Alabama at Birmingham, 901 19th St. South, BMR-2, Rm. 307, Birmingham, AL 35294 (E-mail: patel{at}path.uab.edu ) |
---|---|
AbstractList | The antiatherogenic effects of soy isoflavone consumption have been demonstrated in a variety of studies. However, the mechanisms involved remain poorly defined. Adhesion of monocytes to vascular endothelial cells is a key step within the inflammatory cascade that leads to atherogenesis. Many factors, including the physical forces associated with blood flow, regulate this process. Using an in vitro flow assay, we report that genistein, a principal component of most isoflavone preparations, inhibits monocyte adhesion to cytokine (TNF-alpha)-stimulated human vascular endothelial cells at physiologically relevant concentrations (0-1 microM). This effect is absolutely dependent on flow and is not observed under static conditions. Furthermore, this inhibition was dependent on activation of endothelial peroxisomal proliferator-activated receptor-gamma. No significant role for other reported properties of genistein, including antioxidant effects, inhibition of tyrosine kinases, or activation of estrogen receptors, was observed. Furthermore, the antiadhesive effects of genistein did not occur via modulation of the adhesion molecules E-selectin, ICAM-1, VCAM-1, or platelet-endothelial cell adhesion molecule-1. These data reveal a novel anti-inflammatory mechanism for isoflavones and identify the physical forces associated with blood flow and a critical mediator of this function. The antiatherogenic effects of soy isoflavone consumption have been demonstrated in a variety of studies. However, the mechanisms involved remain poorly defined. Adhesion of monocytes to vascular endothelial cells is a key step within the inflammatory cascade that leads to atherogenesis. Many factors, including the physical forces associated with blood flow, regulate this process. Using an in vitro flow assay, we report that genistein, a principal component of most isoflavone preparations, inhibits monocyte adhesion to cytokine (TNF-α)-stimulated human vascular endothelial cells at physiologically relevant concentrations (0–1 μM). This effect is absolutely dependent on flow and is not observed under static conditions. Furthermore, this inhibition was dependent on activation of endothelial peroxisomal proliferator-activated receptor-γ. No significant role for other reported properties of genistein, including antioxidant effects, inhibition of tyrosine kinases, or activation of estrogen receptors, was observed. Furthermore, the antiadhesive effects of genistein did not occur via modulation of the adhesion molecules E-selectin, ICAM-1, VCAM-1, or platelet-endothelial cell adhesion molecule-1. These data reveal a novel anti-inflammatory mechanism for isoflavones and identify the physical forces associated with blood flow and a critical mediator of this function. Departments of 1 Pathology, 2 Pharmacology, and 3 Anesthesiology, 4 Purdue-University of Alabama at Birmingham Botanical Center for Age-Related Disease, and 5 Center for Free Radical Biology, University of Alabama at Birmingham; and 6 Research Service, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama; and 7 Department of Pathology, Louisiana State University, Shreveport, Louisiana Submitted 2 August 2004 ; accepted in final form 28 March 2005 The antiatherogenic effects of soy isoflavone consumption have been demonstrated in a variety of studies. However, the mechanisms involved remain poorly defined. Adhesion of monocytes to vascular endothelial cells is a key step within the inflammatory cascade that leads to atherogenesis. Many factors, including the physical forces associated with blood flow, regulate this process. Using an in vitro flow assay, we report that genistein, a principal component of most isoflavone preparations, inhibits monocyte adhesion to cytokine (TNF- )-stimulated human vascular endothelial cells at physiologically relevant concentrations (01 µM). This effect is absolutely dependent on flow and is not observed under static conditions. Furthermore, this inhibition was dependent on activation of endothelial peroxisomal proliferator-activated receptor- . No significant role for other reported properties of genistein, including antioxidant effects, inhibition of tyrosine kinases, or activation of estrogen receptors, was observed. Furthermore, the antiadhesive effects of genistein did not occur via modulation of the adhesion molecules E-selectin, ICAM-1, VCAM-1, or platelet-endothelial cell adhesion molecule-1. These data reveal a novel anti-inflammatory mechanism for isoflavones and identify the physical forces associated with blood flow and a critical mediator of this function. inflammation; genistein; peroxisomal proliferator-activated receptor- ; atherosclerosis; monocytes Address for reprint requests and other correspondence: R. P. Patel, Dept. of Pathology, Univ. of Alabama at Birmingham, 901 19th St. South, BMR-2, Rm. 307, Birmingham, AL 35294 (E-mail: patel{at}path.uab.edu ) |
Author | Parks, Dale A Chandler, Robert T Chacko, Balu K Khoo, Nicholas Pruitt, Heather M Kucik, Dennis F Barnes, Stephen Patel, Rakesh P Mundhekar, Ameya Kevil, Christopher G |
Author_xml | – sequence: 1 fullname: Chacko, Balu K – sequence: 2 fullname: Chandler, Robert T – sequence: 3 fullname: Mundhekar, Ameya – sequence: 4 fullname: Khoo, Nicholas – sequence: 5 fullname: Pruitt, Heather M – sequence: 6 fullname: Kucik, Dennis F – sequence: 7 fullname: Parks, Dale A – sequence: 8 fullname: Kevil, Christopher G – sequence: 9 fullname: Barnes, Stephen – sequence: 10 fullname: Patel, Rakesh P |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15805228$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kMtO5DAQRS3EaGiY-QIk5B9IY8d5OOxGaHhISEgjZm05drljcOwodkPn70loHitWtahzr67OMTr0wQNCp5SsKS3zc_k4dCDHtCak5nSdE1IcoNX8yTNasuYQrQirWFZRVh6h4xgfCSFlXbGf6IiWnMwcX6HdP3gG6azfYOmTzaw3Tva9TGGccA-qk97GPuJgcAwTtjHM_-d5SMTthI0LLxe4D3rrZLLBL5iD7VNQU4IMvA6pA2elwwqcw9YnGKVayPgL_TDSRfj9fk_Q_6u_D5c32d399e3ln7tMsYalDIrC1DUHSqrS8IJxqSrNCYDWDSctK2QpeZ2TtpCaGM2qMm9VM_tQM9dyw04Q2_eqMcQ4ghHDaHs5ToISsXgUHx7Fm0exeJxTZ_vUsG170F-Zd3EzcLEHOrvpXuwIYuimaIMLm0lcbZ17gF36rM55I3Jx0xAuBr1sWn8f_pzzFWKvug2chQ |
CitedBy_id | crossref_primary_10_1097_JTO_0000000000000677 crossref_primary_10_3390_fib12040031 crossref_primary_10_1007_s10495_008_0283_9 crossref_primary_10_3945_jn_109_120626 crossref_primary_10_1007_s00394_013_0509_7 crossref_primary_10_1177_2156587215595146 crossref_primary_10_1016_j_brainres_2019_146434 crossref_primary_10_1016_j_jnutbio_2009_09_002 crossref_primary_10_1093_jn_136_9_2384 crossref_primary_10_3390_ijms17081318 crossref_primary_10_1002_mabi_202100114 crossref_primary_10_1007_s11101_015_9398_0 crossref_primary_10_1093_ndt_gfl169 crossref_primary_10_1016_j_nutres_2009_09_002 crossref_primary_10_1080_00397911_2020_1792932 crossref_primary_10_1097_HJH_0b013e32835c0905 crossref_primary_10_1017_S0007114511002571 crossref_primary_10_1016_j_tet_2021_132573 crossref_primary_10_1016_j_heliyon_2023_e13352 crossref_primary_10_1111_j_1467_789X_2008_00554_x crossref_primary_10_13005_bbra_2986 crossref_primary_10_1016_j_aninu_2023_12_005 crossref_primary_10_1016_j_jss_2009_04_048 crossref_primary_10_1007_s00394_012_0331_7 crossref_primary_10_4236_fns_2013_48A002 crossref_primary_10_1074_jbc_M111_247981 crossref_primary_10_1111_j_1467_789X_2009_00644_x crossref_primary_10_1016_j_cyto_2008_06_016 crossref_primary_10_1093_jn_138_2_332 crossref_primary_10_31393_reports_vnmedical_2023_27_4__26 crossref_primary_10_1002_adhm_201701175 crossref_primary_10_1016_j_clnu_2018_09_007 crossref_primary_10_1016_j_neuint_2012_04_007 crossref_primary_10_1210_en_2009_1294 crossref_primary_10_1155_2016_5457010 crossref_primary_10_1002_bit_23073 crossref_primary_10_1016_j_scienta_2019_108669 crossref_primary_10_1111_j_1398_9995_2006_01135_x crossref_primary_10_1152_ajpregu_00031_2010 crossref_primary_10_1016_j_nutres_2013_08_009 crossref_primary_10_1111_j_1525_139X_2008_00445_x crossref_primary_10_1016_j_numecd_2010_05_007 crossref_primary_10_1159_000110446 crossref_primary_10_3390_ijms22115656 crossref_primary_10_1093_jn_137_2_351 crossref_primary_10_1080_22311866_2019_1649194 crossref_primary_10_1080_10408398_2019_1630598 crossref_primary_10_1002_mnfr_200800010 crossref_primary_10_1016_j_ctim_2021_102764 crossref_primary_10_1016_j_ejmech_2013_09_042 crossref_primary_10_1021_jf071851u crossref_primary_10_1155_2010_153252 crossref_primary_10_1139_Y08_085 crossref_primary_10_1016_j_jff_2021_104499 crossref_primary_10_3390_antibiotics10020161 crossref_primary_10_1016_j_tetlet_2015_02_072 crossref_primary_10_1016_j_tet_2007_01_062 crossref_primary_10_1016_j_jnutbio_2007_10_006 crossref_primary_10_1016_j_colsurfb_2013_02_013 crossref_primary_10_1002_mnfr_201300318 crossref_primary_10_1016_j_exer_2016_03_024 crossref_primary_10_3390_ijms231911921 crossref_primary_10_1016_j_freeradbiomed_2017_07_019 crossref_primary_10_1002_ptr_7068 crossref_primary_10_3390_ijms241914494 crossref_primary_10_1016_j_bmc_2014_08_010 crossref_primary_10_3389_fmicb_2018_01182 crossref_primary_10_1016_j_tetasy_2017_07_004 crossref_primary_10_1111_j_1753_4887_2009_00191_x crossref_primary_10_3390_ijms20194957 crossref_primary_10_1080_10408398_2017_1345853 |
Cites_doi | 10.1093/jn/130.8.1887 10.1093/jn/133.5.1238 10.1016/S0021-9258(18)45614-1 10.1073/pnas.95.6.3106 10.1093/jn/133.2.399 10.1023/A:1015911519713 10.1074/jbc.M207800200 10.1161/01.CIR.0000139850.08365.EC 10.1038/35025203 10.1042/bj20020046 10.1210/er.2003-0036 10.1152/ajpcell.2001.281.5.C1442 10.1210/endo.139.10.6216 10.1016/S0735-1097(00)00590-8 10.1152/ajpcell.00334.2002 10.1194/jlr.R400001-JLR200 10.1016/j.metabol.2004.01.019 10.1016/S0891-5849(00)00235-5 10.1097/00001573-200011000-00007 10.1093/jn/134.5.1225S 10.1038/nm1102-1211 10.1093/jn/134.5.1229S 10.1093/ajcn/72.2.395 10.1006/bbrc.1994.2202 10.1016/S0006-2952(99)00409-8 10.1074/jbc.M203436200 10.1016/S0002-9343(03)00059-7 10.1016/j.bbagen.2003.12.008 10.1016/S0021-9150(02)00013-8 10.1038/nm1102-1235 10.1016/j.freeradbiomed.2003.12.012 10.1161/01.CIR.94.7.1682 10.1177/1358836X0000500108 10.1079/BJN2003820 10.1074/jbc.M005036200 10.1161/01.ATV.19.9.2094 10.1161/01.CIR.103.2.258 10.1016/S0891-5849(01)00737-7 10.1073/pnas.0408384102 10.1007/s00011-003-1182-8 10.1111/j.1749-6632.2001.tb03925.x 10.1002/biof.5520120133 10.1016/0891-5849(95)02173-6 10.1177/174182670100800402 10.1016/j.freeradbiomed.2003.08.009 10.1074/jbc.M209483200 10.1016/j.steroids.2004.05.016 10.1016/S0950-351X(98)80006-2 10.1016/S0928468002000834 10.1016/S0891-5849(00)00322-1 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION |
DOI | 10.1152/ajpheart.00781.2004 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1522-1539 |
EndPage | H915 |
ExternalDocumentID | 10_1152_ajpheart_00781_2004 15805228 ajpheart_289_2_H908 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Research Support, U.S. Gov't, P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R21 AI-054552 – fundername: NIEHS NIH HHS grantid: R03 ES/DK-11504 – fundername: NCCIH NIH HHS grantid: P50 AT-00477 |
GroupedDBID | - 02 23M 2WC 39C 53G 5GY 5VS 8M5 ABFLS ABPTK ACIWK ACPRK ADACO ADBBV AENEX AFFNX AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BKOMP C1A DIK DL E3Z EBS EJD F5P GX1 H13 KQ8 O0- OK1 P2P PQEST PQQKQ RAP RHF RHI RPL UKR WH7 WOQ --- 3O- 4.4 6J9 AAFWJ ABJNI ACBEA BKKCC BTFSW CGR CUY CVF ECM EIF EMOBN ITBOX NPM RPRKH TR2 W8F XSW YSK YYP ~02 AAYXX CITATION |
ID | FETCH-LOGICAL-c393t-e44f778e1065f8438ac6d80eedd980b34a5a8720b4ad0fd3652bc9781cc6db8f3 |
ISSN | 0363-6135 |
IngestDate | Fri Aug 23 00:49:53 EDT 2024 Sat Nov 02 12:30:58 EDT 2024 Tue Jan 05 18:11:20 EST 2021 Mon May 06 11:35:55 EDT 2019 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c393t-e44f778e1065f8438ac6d80eedd980b34a5a8720b4ad0fd3652bc9781cc6db8f3 |
PMID | 15805228 |
ParticipantIDs | highwire_physiology_ajpheart_289_2_H908 crossref_primary_10_1152_ajpheart_00781_2004 pubmed_primary_15805228 |
PublicationCentury | 2000 |
PublicationDate | 20050801 2005-Aug 2005-08-00 |
PublicationDateYYYYMMDD | 2005-08-01 |
PublicationDate_xml | – month: 08 year: 2005 text: 20050801 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | American journal of physiology. Heart and circulatory physiology |
PublicationTitleAlternate | Am J Physiol Heart Circ Physiol |
PublicationYear | 2005 |
References | R21 R20 R23 R22 R25 R24 R27 R26 R29 R28 R1 R2 R3 R4 R5 R6 R7 R8 R9 R30 R32 R31 R34 R33 R36 R35 R38 R37 R39 R41 R40 R43 R42 R45 R44 R47 R46 R49 R48 R50 R10 R12 R11 R14 R13 R16 R15 R18 R17 R19 |
References_xml | – ident: R49 doi: 10.1093/jn/130.8.1887 – ident: R28 doi: 10.1093/jn/133.5.1238 – ident: R1 doi: 10.1016/S0021-9258(18)45614-1 – ident: R42 doi: 10.1073/pnas.95.6.3106 – ident: R50 doi: 10.1093/jn/133.2.399 – ident: R31 doi: 10.1023/A:1015911519713 – ident: R29 doi: 10.1074/jbc.M207800200 – ident: R26 doi: 10.1161/01.CIR.0000139850.08365.EC – ident: R27 doi: 10.1038/35025203 – ident: R6 doi: 10.1042/bj20020046 – ident: R22 doi: 10.1210/er.2003-0036 – ident: R21 doi: 10.1152/ajpcell.2001.281.5.C1442 – ident: R23 doi: 10.1210/endo.139.10.6216 – ident: R25 doi: 10.1016/S0735-1097(00)00590-8 – ident: R20 doi: 10.1152/ajpcell.00334.2002 – ident: R30 doi: 10.1194/jlr.R400001-JLR200 – ident: R48 doi: 10.1016/j.metabol.2004.01.019 – ident: R33 doi: 10.1016/S0891-5849(00)00235-5 – ident: R14 doi: 10.1097/00001573-200011000-00007 – ident: R2 doi: 10.1093/jn/134.5.1225S – ident: R39 doi: 10.1038/nm1102-1211 – ident: R12 doi: 10.1093/jn/134.5.1229S – ident: R47 doi: 10.1093/ajcn/72.2.395 – ident: R40 doi: 10.1006/bbrc.1994.2202 – ident: R41 doi: 10.1016/S0006-2952(99)00409-8 – ident: R46 doi: 10.1074/jbc.M203436200 – ident: R37 doi: 10.1016/S0002-9343(03)00059-7 – ident: R35 doi: 10.1016/j.bbagen.2003.12.008 – ident: R38 doi: 10.1016/S0021-9150(02)00013-8 – ident: R24 doi: 10.1038/nm1102-1235 – ident: R34 doi: 10.1016/j.freeradbiomed.2003.12.012 – ident: R43 doi: 10.1161/01.CIR.94.7.1682 – ident: R8 doi: 10.1177/1358836X0000500108 – ident: R15 doi: 10.1079/BJN2003820 – ident: R16 doi: 10.1074/jbc.M005036200 – ident: R18 doi: 10.1161/01.ATV.19.9.2094 – ident: R45 doi: 10.1161/01.CIR.103.2.258 – ident: R32 doi: 10.1016/S0891-5849(01)00737-7 – ident: R36 doi: 10.1073/pnas.0408384102 – ident: R44 doi: 10.1007/s00011-003-1182-8 – ident: R10 doi: 10.1111/j.1749-6632.2001.tb03925.x – ident: R3 doi: 10.1002/biof.5520120133 – ident: R4 doi: 10.1016/0891-5849(95)02173-6 – ident: R11 doi: 10.1177/174182670100800402 – ident: R5 doi: 10.1016/j.freeradbiomed.2003.08.009 – ident: R9 doi: 10.1074/jbc.M209483200 – ident: R13 doi: 10.1016/j.steroids.2004.05.016 – ident: R7 doi: 10.1016/S0950-351X(98)80006-2 – ident: R19 doi: 10.1016/S0928468002000834 – ident: R17 doi: 10.1016/S0891-5849(00)00322-1 |
SSID | ssj0005763 |
Score | 2.1844742 |
Snippet | Departments of 1 Pathology, 2 Pharmacology, and 3 Anesthesiology, 4 Purdue-University of Alabama at Birmingham Botanical Center for Age-Related Disease, and 5... The antiatherogenic effects of soy isoflavone consumption have been demonstrated in a variety of studies. However, the mechanisms involved remain poorly... |
SourceID | crossref pubmed highwire |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | H908 |
SubjectTerms | Anti-Inflammatory Agents - pharmacology Aorta Cell Adhesion - drug effects Cell Adhesion Molecules - metabolism Cell Communication - drug effects Cells, Cultured Endothelial Cells - physiology Genistein - pharmacology Glycine max - chemistry Humans Isoflavones - pharmacology Leukocytes - physiology Monocytes - physiology Phosphorylation PPAR gamma - physiology Reactive Oxygen Species - metabolism Receptors, Estrogen - metabolism Stress, Mechanical Tumor Necrosis Factor-alpha - pharmacology Tyrosine - metabolism |
Title | Revealing anti-inflammatory mechanisms of soy isoflavones by flow: modulation of leukocyte-endothelial cell interactions |
URI | http://ajpheart.physiology.org/cgi/content/abstract/289/2/H908 https://www.ncbi.nlm.nih.gov/pubmed/15805228 |
Volume | 289 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKkBAvCDY-ypf8gOChpGRx0ia8TQhUUQ0B6qS9RfFHtK5NUrXpIPy9_CHcxUnsbRVivERVYluX3i_23fnuZ0JeJUqMkmisHOFj6CZVhw5nCXgpQjCJ_FJ-Hcw5_jKanPifT4PTXu-3lbW0LflQ_NpZV_I_WoV7oFeskr2BZrtB4Qb8Bv3CFTQM13_S8Xd1AXaeLjMs5w4MCfrN9L55prCmd77J6lyNTVEN5psCnl8gOT8anemy-IHxgKyQzRFe2HCptotCVKVyVC6xOmuJIXUM79fMEmtdB7Gxbdpu08dioagDJnXEfoiVTmudxy7ma0x7reUzLawMA7Eo9CbIcjuYDq0HSAVhZYIPZkODlFyeqYXOEwdRqm6dmZ4VRQN2dOAvBziCLr3OFHYx8HA1q8lQNfM0-NAwWUf2RO7pw4gaxHrWtDyJ3NBa4ieRLiG9vnwESEebnK_wNPESadVDHUMwq2WbIXBlEe1SG2unKvDidpC4HgRP-_RvkdseTIc4D0-_GU578PhYu6OOr9lwY8Eg73ZIctl-ajmtrzhFtXE0u0_uNV4NPdIQfUB6Kt8nB0c5qDqr6Gv6tVP2Prlz3KRzHJCfHYDpNQBTA2BapBQATC0AU15RBPB7auCLzXbClyJ8qQ3fh-Tk08fZh4nTHAXiCBax0lG-n47HoToEizkNfRYmYiRDFww8GYUuZ34SJOHYc7mfSDeVbBR4XCCdm4B2PEzZI7KXg3hPCAUHPgWbVnrS5-DuMy7cgCvo4krOAyX75G37B8crzfgS_0WpfcJaJcTmy4kxgDQDZHRdAJyxFyMQ45VM--TNrl7d-KZ1nzzWmjXCBHgMiRc-vZmgz8hd83U9J3vleqtegEFd8pc1Hv8A_ETXMg |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Revealing+anti-inflammatory+mechanisms+of+soy+isoflavones+by+flow%3A+modulation+of+leukocyte-endothelial+cell+interactions&rft.jtitle=American+journal+of+physiology.+Heart+and+circulatory+physiology&rft.au=Chacko%2C+Balu+K.&rft.au=Chandler%2C+Robert+T.&rft.au=Mundhekar%2C+Ameya&rft.au=Khoo%2C+Nicholas&rft.date=2005-08-01&rft.issn=0363-6135&rft.eissn=1522-1539&rft.volume=289&rft.issue=2&rft.spage=H908&rft.epage=H915&rft_id=info:doi/10.1152%2Fajpheart.00781.2004&rft.externalDBID=n%2Fa&rft.externalDocID=10_1152_ajpheart_00781_2004 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0363-6135&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0363-6135&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0363-6135&client=summon |